Search Login Register
Thanatophoric Dysplasia
(Dwarfism, Thanatophoric)
Summary
75
relevant articles (0 outcomes,
4 trials/studies)
found for this Disease
Description:
A severe form of neonatal dwarfism with very short limbs. All cases have died at birth or later in the neonatal period.
Also Known As:
Dwarfism, Thanatophoric; Thanatophoric Dwarfism; Dwarfisms, Thanatophoric; Dysplasia, Thanatophoric; Dysplasias, Thanatophoric Show All >>
Key Drugs and Agents for Thanatophoric Dysplasia
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
:
1 study in 39 results
: IBA
-
Messenger RNA (mRNA)
:
1 study in 3 results
: IBA
-
Proteoglycans (Proteoglycan)
:
1 study in 2 results
: IBA
-
Fibroblast Growth Factor 3
:
1 study in 1 result
: IBA
-
Parathyroid Hormone-Related Protein
:
1 study in 1 result
: IBA
-
Phosphotransferases (Kinase)
:
8 results
: IBA
-
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
:
7 results
: IBA
-
Protein-Tyrosine Kinases (Tyrosine Kinase)
:
5 results
: IBA
-
Codon (Codons)
:
5 results
: IBA
-
Cysteine (L-Cysteine)
:
3 results
:
FDA 10
Show All >>
Diseases Related to Thanatophoric Dysplasia
-
Achondroplasia
-
Syndrome
-
Ellis-Van Creveld Syndrome (Chondroectodermal Dysplasia)
-
Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
-
Chondrodysplasia Punctata (Stippled Epiphyses)
Show All >>
Key Therapies for Thanatophoric Dysplasia
Efficacy Chart >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.